(18)F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer

There is an unmet need for predictive biomarkers of the clinical benefit of antiangiogenic drugs. The aim of the present study was to prospectively evaluate the value of (18)F-FDG PET/CT performed during and after preoperative chemoradiotherapy with bevacizumab for the prediction of complete patholo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Nucl Med
Main Authors: Avallone, Antonio, Aloj, Luigi, Pecori, Biagio, Caracò, Corradina, De Stefano, Alfonso, Tatangelo, Fabiana, Silvestro, Lucrezia, Granata, Vincenza, Bianco, Francesco, Romano, Carmela, Di Gennaro, Francesca, Budillon, Alfredo, Petrillo, Antonella, Muto, Paolo, Botti, Gerardo, Delrio, Paolo, Lastoria, Secondo
Format: Artigo
Jezik:Inglês
Izdano: Society of Nuclear Medicine 2019
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836863/
https://ncbi.nlm.nih.gov/pubmed/30877175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222604
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki